SEVIPROTIMUT-L
UNII B061MTO20N

Substance Identification & Data

This profile provides standardized clinical and technical data for Seviprotimut-l, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B061MTO20N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
B061MTO20N
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SEVIPROTIMUT-L
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
USAN ID
AB-101
Identifier assigned by the United States Adopted Names Council.
Substance Type
mixture
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Seviprotimut-l. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SEVIPROTIMUT-L

Common Names & Synonyms

HUMAN POLYVALENT SHEDDED ANTIGEN VACCINE
SEVIPROTIMUT L [WHO-DD]
SEVIPROTIMUT-L [USAN]

Technical Codes

POL-103A